GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pheton Holdings Ltd (NAS:PTHL) » Definitions » Investments And Advances

PTHL (Pheton Holdings) Investments And Advances : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pheton Holdings Investments And Advances?

Pheton Holdings's Investments And Advances for the quarter that ended in Dec. 2024 was $0.00 Mil.


Pheton Holdings Investments And Advances Historical Data

The historical data trend for Pheton Holdings's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pheton Holdings Investments And Advances Chart

Pheton Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Investments And Advances
- - - -

Pheton Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Investments And Advances Get a 7-Day Free Trial - - - - -

Pheton Holdings Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Pheton Holdings Business Description

Traded in Other Exchanges
N/A
Address
Hong Jun Ying South Road, Room 306, NET Building, Chaoyang District, Beijing, CHN, 100101
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Pheton Holdings Headlines